The Effect of Neuromuscular Electrical Stimulation (NMES) (NMES)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00765739 |
Recruitment Status
:
Completed
First Posted
: October 3, 2008
Last Update Posted
: January 24, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Muscle Fiber Atrophy, Type II | Other: Neuromuscular electrical stimulation Other: voluntary strengthening exercise | Phase 2 |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 23 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | The Effect of Neuromuscular Electrical Stimulation (NMES) in Inducing Muscle Hypertrophy and Improvement in Muscle Torque Output Within the Quadriceps Muscle of Elderly People |
Study Start Date : | October 2008 |
Actual Primary Completion Date : | August 2012 |
Actual Study Completion Date : | August 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
The group who will get neuromuscular electrical stimulation (NMES)
|
Other: Neuromuscular electrical stimulation
neuromuscular electrical stimulation that produce 40% of the maximum voluntary contraction
|
Active Comparator: 2
The group who will do the voluntary muscle contraction
|
Other: voluntary strengthening exercise
contracting the quadriceps muscle voluntarily to produce 40% of maximum voluntary contraction
|
- Cross sectional area of type II muscle fibers [ Time Frame: Base line and 3 months follow up ]
- Quadriceps muscle power output [ Time Frame: baseline and 3 month follow up ]
- Functional performance [ Time Frame: baseline and 3 month follow up ]
- Quadriceps muscle cross sectional area [ Time Frame: baseline and 3 month follow up ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 65-80 years old, are walking independently without assistive devices.
Exclusion Criteria:
- Uncontrolled hypertension (defined as the following: 1) if not taking BP medication and resting systolic BP is greater than 140 or diastolic greater than 90, or 2) if taking BP medication and resting systolic BP greater than 160 or diastolic greater than 100).
- History of cardiovascular disease
- History of neurological disorders that effect lower extremity function (stroke, peripheral neuropathy, Parkinson's disease, multiple sclerosis)
- One cortico-steroid injection to the quadriceps or patellar tendon in the past month or 3 within the past year.
- History of quadriceps tendon rupture, patellar tendon rupture, or patellar fracture, which could place them at risk of re-injury during quadriceps strength testing.
- Current pain in the knee or in the thigh muscles.
- Diagnosis of inflammatory arthritis (Rheumatoid arthritis, gout, or psoriatic arthritis)
- Muscle diseases such as muscular dystrophy.
- Currently been participating in a regular exercise program more than 1x/week.
- Been using anticoagulants and platelet inhibitors
- History of chronic and significant respiratory disease or shortness of breath
- Visual impairments to the extent that they can not accurately see the monitor screen during training program.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00765739
United States, Pennsylvania | |
School of Health and Rehabilitation Sciences | |
Pittsburgh, Pennsylvania, United States, 15260 |
Responsible Party: | University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT00765739 History of Changes |
Other Study ID Numbers: |
NMES1 |
First Posted: | October 3, 2008 Key Record Dates |
Last Update Posted: | January 24, 2013 |
Last Verified: | January 2013 |
Keywords provided by University of Pittsburgh:
muscle fibers aging |
Additional relevant MeSH terms:
Atrophy Pathological Conditions, Anatomical |